We have purified and characterized the cerebral amyloid protein that forms the plaque core
in Alzheimer disease and in aged individuals with Down syndrome. The protein consists of …

Alzheimer's disease 1 is characterized by a widespread functional disturbance of the human
brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles 2 …

Background The order and magnitude of pathologic processes in Alzheimer's disease are
not well understood, partly because the disease develops over many years. Autosomal …

Oxidative stress has been implicated in the progression of Alzheimer's disease, Parkinson's
disease and amyotrophic lateral sclerosis. Oxygen is vital for life but is also potentially …

Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the
center of Alzheimer’s disease (AD) pathophysiology. While the detailed molecular mechanisms …

Background Similar to most chronic diseases, Alzheimer's disease (AD) develops slowly from
a preclinical phase into a fully expressed clinical syndrome. We aimed to use longitudinal …

Genetic evidence strongly supports the view that Aβ amyloid production is central to the cause
of Alzheimer's disease. The kinetics, compartmentation, and form of Aβ and its temporal …

Inhibition of neocortical β-amyloid (Aβ) accumulation may be essential in an effective therapeutic
intervention for Alzheimer's disease (AD). Cu and Zn are enriched in Aβ deposits in AD, …

Alzheimer's disease is a chronic illness with long preclinical and prodromal phases (20 years)
and an average clinical duration of 8–10 years. The disease has an estimated prevalence …

Aβ 1-40 , a major component of Alzheimer's disease cerebral amyloid, is present in the
cerebrospinal fluid and remains relatively soluble at high concentrations (less than or equal to …